MODEL VERDICT
Tonix Pharmaceuticals Holding Corp. (TNXP) — Relative Valuation
Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 182 industry peers | $82.28 | +406.3% | 4% | B | Data |
| Price / Sales 184 industry peers | $38.50 | +136.9% | 3% | B | Model Driven |
| Weighted Output Blended model output | $60.32 | +271.2% | 100% | 59 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 11946.81 | 115.55 | 0.54 | 63946.58 | 23442.98 |
| P/B Ratio | 11938.96 | 115.48 | 0.53 | 63946.58 | 23444.37 |
Based on our peer multiples analysis with 4 valuation metrics, the model estimates TNXP's fair value at $60.32 vs the current price of $16.25, implying +271.2% upside potential. Model verdict: Significantly Undervalued. Confidence: 59/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $60.32 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $42.71 (P10) to $85.48 (P90), with a median of $63.52.
TNXP's current P/E of -0.1x compares to the industry median of 23.5x (45 peers in the group). This represents a -100.4% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
7 analysts cover TNXP with a consensus rating of Buy. The consensus price target is N/A (range: N/A — N/A), implying N/A upside from the current price. Grade breakdown: Strong Buy (0), Buy (6), Hold (1), Sell (0), Strong Sell (0).
The model confidence score is 59/100, based on: data completeness (6), peer quality (25), historical depth (20), earnings stability (5), and model agreement (3). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for TNXP.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.